Il y a eu 50 transactions d'initiés récentes enregistrées pour Roivant Sciences Ltd. (ROIV), dont 1 achat et 48 ventes. Le total des achats d'initiés s'élève à $3.94M et le total des ventes d'initiés à $255.11M.
Les initiés notables ayant une activité récente comprennent Sukhatme Mayukh, Gline Matthew, Torti Frank. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ROIV
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-31 |
Sukhatme Mayukh |
President & CIO |
Retenue Fiscale RSU |
187,512 |
$27.70 |
$5.19M |
18,677,617 |
| 2026-03-31 |
Gline Matthew |
CEO |
Retenue Fiscale RSU |
304,684 |
$27.70 |
$8.44M |
17,025,890 |
| 2026-03-31 |
Torti Frank |
President and Vant Chair |
Retenue Fiscale RSU |
160,035 |
$27.70 |
$4.43M |
13,576,512 |
| 2026-03-30 |
Sukhatme Mayukh |
President & CIO |
Exercice d'Options (Vente) |
1,306,889 |
- |
- |
- |
| 2026-03-30 |
Gline Matthew |
CEO |
Exercice d'Options (Vente) |
2,178,150 |
- |
- |
- |
| 2026-03-26 |
Fitzgerald Meghan |
Director |
Vente Informative |
70,000 |
$27.45 |
$1.92M |
42,963 |
| 2026-03-20 |
Pulik Richard |
CFO |
Retenue Fiscale RSU |
1,546 |
$27.70 |
$42.82K |
236,867 |
| 2026-03-20 |
Humes Jennifer |
Chief Accounting Officer |
Retenue Fiscale RSU |
14,526 |
$27.70 |
$402.37K |
97,729 |
| 2026-03-17 |
Venker Eric |
President & Immunovant CEO |
Vente Informative |
200,000 |
$28.24 |
$5.65M |
1,647,546 |
| 2026-03-16 |
Epperly Melissa B, |
Director |
Vente Informative |
41,861 |
$28.68 |
$1.2M |
15,804 |
| 2026-02-23 |
Torti Frank |
President and Vant Chair |
Exercice d'Options (Vente) |
587,390 |
$3.85 |
$2.26M |
3,026,184 |
| 2026-02-20 |
Torti Frank |
President and Vant Chair |
Exercice d'Options (Vente) |
1,012,610 |
$3.85 |
$3.9M |
3,613,574 |
| 2026-02-20 |
Venker Eric |
President & Immunovant CEO |
Retenue Fiscale RSU |
7,051 |
$27.15 |
$191.43K |
1,647,546 |
| 2026-02-20 |
Pulik Richard |
CFO |
Retenue Fiscale RSU |
1,000 |
$27.15 |
$27.15K |
238,413 |
| 2026-02-19 |
Torti Frank |
President and Vant Chair |
Exercice d'Options (Vente) |
1,400,000 |
$3.85 |
$5.39M |
4,626,184 |
| 2026-02-13 |
Manchester Keith S |
Director |
Vente Informative |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Qvt Financial Lp |
Other: Director By Deputization |
Vente Informative |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Gold Daniel Allen |
Director |
Vente Informative |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Venker Eric |
President & Immunovant CEO |
Vente Informative |
200,000 |
$26.49 |
$5.3M |
1,654,597 |
| 2026-02-12 |
Manchester Keith S |
Director |
Vente Informative |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Qvt Financial Lp |
Other: Director By Deputization |
Vente Informative |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Gold Daniel Allen |
Director |
Vente Informative |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-11 |
Manchester Keith S |
Director |
Vente Informative |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Qvt Financial Lp |
Other: Director By Deputization |
Vente Informative |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Gold Daniel Allen |
Director |
Vente Informative |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-09 |
Sukhatme Mayukh |
President & CIO |
Exercice d'Options (Vente) |
651,558 |
$12.68 |
$8.26M |
- |
| 2026-01-20 |
Momtazee James C |
Director |
Retenue Fiscale RSU |
122 |
$22.98 |
$2.8K |
109,030 |
| 2026-01-20 |
Oren Ilan |
Director |
Retenue Fiscale RSU |
124 |
$22.98 |
$2.85K |
119,428 |
| 2026-01-20 |
Epperly Melissa B, |
Director |
Retenue Fiscale RSU |
54 |
$22.98 |
$1.24K |
57,665 |
| 2026-01-12 |
Venker Eric |
President & Immunovant CEO |
Vente Informative |
200,000 |
$21.92 |
$4.38M |
1,654,597 |
| 2025-12-31 |
Sukhatme Mayukh |
President & CIO |
Exercice d'Options (Vente) |
2,449,877 |
$12.68 |
$31.06M |
95,718 |
| 2025-12-29 |
Sukhatme Mayukh |
President & CIO |
Exercice d'Options (Vente) |
748,358 |
$12.68 |
$9.49M |
555,840 |
| 2025-12-24 |
Torti Frank |
President and Vant Chair |
Don (Donné) |
110,489 |
- |
- |
13,736,547 |
| 2025-12-24 |
Venker Eric |
President & Immunovant CEO |
Vente Informative |
75,000 |
$22.53 |
$1.69M |
1,654,597 |
| 2025-12-23 |
Torti Frank |
President and Vant Chair |
Attribution de RSU |
175,380 |
$22.45 |
$3.94M |
13,911,927 |
| 2025-12-23 |
Venker Eric |
President & Immunovant CEO |
Vente Informative |
200,000 |
$22.45 |
$4.49M |
1,611,749 |
| 2025-12-23 |
Pulik Richard |
CFO |
Vente Informative |
146,731 |
$22.39 |
$3.29M |
239,413 |
| 2025-12-20 |
Pulik Richard |
CFO |
Retenue Fiscale RSU |
2,129 |
$22.41 |
$47.71K |
386,144 |
| 2025-12-17 |
Manchester Keith S |
Director |
Vente Informative |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Qvt Financial Lp |
Other: Director By Deputization |
Vente Informative |
155,076 |
$23.02 |
$3.57M |
16,542,651 |
| 2025-12-17 |
Gold Daniel Allen |
Director |
Vente Informative |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Sukhatme Mayukh |
President & CIO |
Exercice d'Options (Vente) |
59,513 |
$12.68 |
$754.62K |
1,304,198 |
| 2025-12-16 |
Manchester Keith S |
Director |
Vente Informative |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Qvt Financial Lp |
Other: Director By Deputization |
Vente Informative |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Gold Daniel Allen |
Director |
Vente Informative |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-06-20 |
Ramaswamy Vivek |
10 Percent Owner |
Vente Informative |
577,007 |
$11.46 |
$6.61M |
37,284,108 |
| 2025-06-20 |
Venker Eric |
President & COO |
Vente Informative |
100,000 |
$11.45 |
$1.15M |
1,462,223 |
| 2025-06-20 |
Pulik Richard |
CFO |
Retenue Fiscale RSU |
1,503 |
$11.45 |
$17.21K |
399,056 |
| 2025-06-18 |
Ramaswamy Vivek |
10 Percent Owner |
Vente Informative |
565,266 |
$11.45 |
$6.47M |
37,861,115 |
| 2025-06-06 |
Ramaswamy Vivek |
10 Percent Owner |
Vente Informative |
200,800 |
$11.19 |
$2.25M |
38,426,381 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
